Featured Stories
We Maintain the Best Balance Between Development and Risk
Interview with Erna Slana, Managing Director of the Finance and Accounting Division at Medis.
Read MoreMedis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read MoreMedis Received the Platinum Creditworthiness Certificate of Excellence for 2020
The Bisnode Analytics Services has ranked Medis among the 1.5% of the most successful, reliable, credible and low-risk companies for cooperation with other...
Read MoreA new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read MoreIn 2019 Medis generated 70% revenues from international markets
The rapid expansion and the introduction of important novel therapeutic options further enhanced the position of Medis as the leading independent company for...
Read MoreMartina Perharič, the CEO of Medis, Recipient of the 2019 Artemis Award
The Managers’ Association of Slovenia presented the award for outstanding achievements in the field of management to Martina Perharič, the CEO of Medis.
Read More